跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
何 淑娟
教授
,
呼吸治療學系
合聘教授
,
醫學院人工智慧醫療碩士在職專班
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0002-1616-8647
電子郵件
shu-chuan
tmu.edu
tw
h-index
952
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2025
每年研究成果
概覽
指紋
網路
專案
(19)
研究成果
(82)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Shu-Chuan Ho 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Air Trapping
8%
Airway Obstruction
9%
Airway Smooth Muscle Cell
6%
Asthma
13%
Atmospheric Aerosol
15%
Biological Marker
10%
Body Mass Index
7%
Carbon Dioxide
7%
Chronic Cough
6%
Chronic Obstructive Pulmonary Disease
100%
Continuous Positive Airway Pressure
15%
Cross Sectional Study
8%
Disease
6%
Disease Exacerbation
7%
Disease Severity
8%
Drive
6%
Emphysema
28%
Eosinophil
8%
Exercise
20%
Forced Expiratory Volume
18%
Forced Vital Capacity
12%
Gastroesophageal Reflux
7%
Heart Rate Variability
7%
Heavy Chain
6%
Heavy Metal
7%
Hydrocortisone
8%
Limb
7%
Long Term Exposure
8%
Long-Term Care
8%
Lung Clearance
8%
Lung Emphysema
8%
Lung Function
16%
Lung Function Test
6%
Mild Cognitive Impairment
6%
Obstructive Lung Disease
6%
Obstructive Sleep Apnea
20%
Odds Ratio
9%
Particular Matter 2.5
31%
Physical Activity
8%
Pleura Effusion
8%
Programmed Cell Death
6%
Pulmonary Rehabilitation
33%
Quality of Life
8%
Rehabilitation Engineering
15%
Respiratory Care
10%
Six Minute Walk Test
12%
Sleep Disorder
8%
Sleep Quality
16%
Urinary System
21%
Walking Distance
9%
Immunology and Microbiology
8 Isoprostane
7%
Airflow
6%
Airway Smooth Muscle Cell
13%
Allergen
6%
Autophagy
6%
C-Reactive Protein
7%
Cadherin
10%
Cluster of Differentiation
6%
Comorbidity
6%
Complement Factor B
6%
Computer Assisted Tomography
6%
Contact Inhibition
6%
Dendritic Cell
6%
Eosinophil Count
6%
Epiregulin
6%
Exercise
13%
Forced Expiratory Volume
19%
Heat
6%
Heavy Chain
6%
Hippo Signaling
13%
Humidity
6%
Immune Response
8%
Immunotherapy
6%
Inflammation Response
7%
Inter-Alpha-Trypsin Inhibitor
6%
Interleukin 8
6%
Interleukin-6
14%
Liquid
6%
Lung Diffusion Capacity
7%
Lung Function
25%
Lymphocyte
8%
Mediator
8%
Mouse
10%
Neutrophil
26%
Neutrophil Count
7%
Normal Human
12%
Oxygen Saturation
11%
Particulate Matter
13%
Peripheral Blood Mononuclear Cell
21%
Physical Activity
8%
Programmed Death 1 Ligand 1
6%
Promoter Region
15%
Proteasome
6%
RNA Polymerase
8%
Signal Transduction
20%
Smooth Muscle
13%
Sulfur Dioxide
8%
Systemic Inflammation
31%
TLR2
6%
Toll-Like Receptor
8%
Pharmacology, Toxicology and Pharmaceutical Science
2,5-Dimethoxy-4-iodoamphetamine
6%
Airway Obstruction
6%
Angiotensin Converting Enzyme 2
6%
Asthma
17%
Biological Marker
7%
Bronchiectasis
6%
Chronic Bronchitis
6%
Chronic Cough
6%
Chronic Obstructive Lung Disease
66%
Ciglitazone
6%
Cohort Study
7%
Disease Model
6%
Elastase
6%
Emphysema
37%
Epiregulin
6%
Gastroesophageal Reflux
7%
Heavy Metal
8%
Hydrocortisone
11%
Immunotherapy
13%
Inflammation
23%
Intercellular Adhesion Molecule 1
6%
Leukocyte Elastase
7%
Long Term Exposure
15%
Lung Cancer
16%
Lung Tuberculosis
6%
Malignant Neoplasm
12%
Malignant Transformation
6%
Methionine Sulfoxide Reductase
6%
Neoplasm
5%
Neutrophil Gelatinase Associated Lipocalin
6%
Nickel Nanoparticle
6%
Obstructive Airway Disease
6%
Peroxisome Proliferator Activated Receptor
6%
Pleura Effusion
18%
Pleurisy
6%
Receptor
6%
Retrospective Study
7%
Serotonin
7%
Sleep Disorder
6%
Sleep Disordered Breathing
6%
Stress Hormone
6%
Survival Rate
5%
Trace Element
6%
Transcription Factor EZH2
6%
Tumor Necrosis Factor
7%
Uvomorulin
8%
Zinc Oxide Nanoparticle
6%
